Multi-jurisdiction trademark coverage reinforces XRP Healthcare’s position across digital health, pharmacy networks, and XRP-based payment infrastructure DUBAI,Multi-jurisdiction trademark coverage reinforces XRP Healthcare’s position across digital health, pharmacy networks, and XRP-based payment infrastructure DUBAI,

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare’s position across digital health, pharmacy networks, and XRP-based payment infrastructure

DUBAI, UAE, Dec. 22, 2025 /PRNewswire/ — XRP Healthcare today announced the continued expansion of its XRP Healthcare® trademark portfolio, securing protection across healthcare services, digital health technology, and payment-related infrastructure in multiple global jurisdictions.

The XRP Healthcare® trademark is registered in the United States under Classes 9 and 44, with established registrations in the United Kingdom, European Union, United Arab Emirates, and Uganda, and additional jurisdictions currently in process as part of the company’s ongoing international trademark strategy.

The trademark registrations in the United Kingdom, European Union, United Arab Emirates, and Uganda were secured and announced over the past two years as part of a phased, jurisdiction-by-jurisdiction approach. These earlier registrations established foundational protection across key healthcare and emerging markets. The recent United States registrations under Classes 9 and 44 further strengthen this framework, completing a multi-market trademark perimeter aligned with healthcare services, digital health, and XRP-powered payment infrastructure.

The dual U.S. trademark coverage provides integrated protection spanning digital health platforms and healthcare software infrastructure, virtual healthcare payment use cases leveraging XRP-based settlement infrastructure, and pharmacy services and healthcare delivery models. This legal framework underpins XRP Healthcare’s operating model at the convergence of healthcare and payments while reducing brand and execution risk.

XRP Healthcare already operates a live Prescription Savings Card program in the United States, accepted at approximately 68,000 pharmacies nationwide and in continuous use since March 2022. This established footprint demonstrates real-world integration within the U.S. healthcare ecosystem and provides a practical distribution foundation for broader digital payment and healthcare initiatives.

The XRP Healthcare® trademark is owned by a related IP holding entity and licensed to the group’s operating companies, including XRP Healthcare LLC, which focuses on healthcare payment infrastructure, wallet technology, and ecosystem tools, and XRP Healthcare M&A Holding Inc., which focuses on healthcare acquisitions, pharmacy networks, AI-enabled healthcare services, and international expansion.

As part of its ecosystem, XRP Healthcare operates the XRPH Wallet, an open-source, non-custodial, XRPL-native payment wallet designed for healthcare-related payment workflows. The wallet does not store or transmit protected health information, follows a HIPAA-grade standard architecture (design-led, not regulatory certification), and supports XRP, XRPH, and RLUSD. Healthcare providers and pharmacies may deploy the XRPH Wallet directly or build their own compliant payment solutions using XRP Healthcare’s open-source framework.

XRP Healthcare’s acquisition and expansion strategy is being executed through XRP Healthcare M&A Holding Inc., which is pursuing a proposed public listing on the TSX Venture Exchange (TSXV) in Canada, subject to regulatory review, market conditions, and customary approvals.

As part of its capital-markets preparation, XRP Healthcare M&A Holding Inc. has engaged experienced capital-markets advisors, including ARC Group, in shaping its public-market structure, governance framework, and transaction readiness. Advisory input has included guidance from ARC Group leadership, including its founder Abraham Cinta, alongside senior advisors such as Charles Chong. These advisory engagements are non-controlling and do not constitute sponsorship, underwriting, or funding commitments.

By securing trademark protection across healthcare services and digital payment infrastructure, XRP Healthcare has established a framework that supports future payment-rail participation, integrations, partnerships, and licensing opportunities aligned with compliant healthcare payment use cases, including pharmacy and provider workflows in the United States and Africa.

About XRP Healthcare

XRP Healthcare is building a global healthcare platform spanning digital payment infrastructure, AI-enabled healthcare tools, and physical healthcare operations, with a focus on compliant architecture, institutional alignment, and sustainable value creation.

For more information, visit: https://www.xrphealthcare.ai, explore the XRP Healthcare ecosystem at www.xrphtoken.com, or follow XRP Healthcare on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements regarding proposed capital-markets activities, planned expansions, anticipated partnerships, healthcare acquisitions, payment-infrastructure development, licensing opportunities, and the potential public listing of XRP Healthcare M&A Holding Inc. on the TSX Venture Exchange.

Forward-looking statements are based on current expectations, assumptions, and estimates and are subject to a number of risks, uncertainties, and other factors that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, regulatory approvals, market conditions, availability of financing, operational execution, and changes in economic or industry conditions. Readers are cautioned not to place undue reliance on forward-looking statements. XRP Healthcare and its affiliated entities undertake no obligation to update or revise forward-looking statements except as required by applicable law.

Contact
Kain Roomes
Founder & CEO
Direct: +971 50 401 0662
www.xrphealthcare.ai 

Photo: https://mma.prnewswire.com/media/2850075/XRP_Healthcare.jpg
Logo: https://mma.prnewswire.com/media/2365357/5691929/XRP_Healthcare_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/xrp-healthcare-secures-global-trademark-protection-at-the-intersection-of-healthcare-services-and-xrp-powered-payments-302647580.html

SOURCE XRP HEALTHCARE LIMITED

Piyasa Fırsatı
XRP Logosu
XRP Fiyatı(XRP)
$1.9056
$1.9056$1.9056
-1.49%
USD
XRP (XRP) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

BOSTON–(BUSINESS WIRE)–MFS Investment Management® (MFS®) released today the distribution income sources for five of its closed-end funds for December 2025: MFS®
Paylaş
AI Journal2025/12/23 05:45
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Paylaş
BitcoinEthereumNews2025/09/18 01:44
Foreigner’s Lou Gramm Revisits The Band’s Classic ‘4’ Album, Now Reissued

Foreigner’s Lou Gramm Revisits The Band’s Classic ‘4’ Album, Now Reissued

The post Foreigner’s Lou Gramm Revisits The Band’s Classic ‘4’ Album, Now Reissued appeared on BitcoinEthereumNews.com. American-based rock band Foreigner performs onstage at the Rosemont Horizon, Rosemont, Illinois, November 8, 1981. Pictured are, from left, Mick Jones, on guitar, and vocalist Lou Gramm. (Photo by Paul Natkin/Getty Images) Getty Images Singer Lou Gramm has a vivid memory of recording the ballad “Waiting for a Girl Like You” at New York City’s Electric Lady Studio for his band Foreigner more than 40 years ago. Gramm was adding his vocals for the track in the control room on the other side of the glass when he noticed a beautiful woman walking through the door. “She sits on the sofa in front of the board,” he says. “She looked at me while I was singing. And every now and then, she had a little smile on her face. I’m not sure what that was, but it was driving me crazy. “And at the end of the song, when I’m singing the ad-libs and stuff like that, she gets up,” he continues. “She gives me a little smile and walks out of the room. And when the song ended, I would look up every now and then to see where Mick [Jones] and Mutt [Lange] were, and they were pushing buttons and turning knobs. They were not aware that she was even in the room. So when the song ended, I said, ‘Guys, who was that woman who walked in? She was beautiful.’ And they looked at each other, and they went, ‘What are you talking about? We didn’t see anything.’ But you know what? I think they put her up to it. Doesn’t that sound more like them?” “Waiting for a Girl Like You” became a massive hit in 1981 for Foreigner off their album 4, which peaked at number one on the Billboard chart for 10 weeks and…
Paylaş
BitcoinEthereumNews2025/09/18 01:26